Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000907451 | SCV001052159 | likely benign | not provided | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004526786 | SCV005039818 | uncertain significance | not specified | 2024-03-18 | criteria provided, single submitter | clinical testing | Variant summary: CACNA1B c.4308+7G>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00048 in 249152 control chromosomes. This frequency does not allow for any conclusion about variant significance. However, Neurodevelopmental Disorder With Seizures And Nonepileptic Hyperkinetic Movements is expected to cause severe, early-onset phenotypes, and this variant has been reported in one homozygous adult in the All Of Us database, suggesting that it may have a benign role in association with this condition. To our knowledge, no occurrence of c.4308+7G>A in individuals affected with Neurodevelopmental Disorder With Seizures And Nonepileptic Hyperkinetic Movements and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 732326). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |
Ce |
RCV000907451 | SCV005891135 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | CACNA1B: BP4 |